Clinical Trial Update: A Trial of Extracorporeal Photopheresis, Pentostatin, and Total Body Irradiation in Patients Undergoing Reduced Intensity Allogeneic Stem Cell Transplantation for the Treatment of Malignancies [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating extracorporeal photopheresis plus pentostatin and total body irradiation as part of reduced-intensity allogeneic stem cell trans…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hematologic Malignancies

Drugs mentioned

• Extracorporeal Photopheresis
• Nipent (pentostatin) (pentostatin)
• Total Body Irradiation

Snippet

Sponsor: Yale University | Conditions: Hematologic Malignancies | Phase 2 | Status: COMPLETED | Results posted: 2017-01-18